ArticleFrontiers in pediatrics2025
Analysis of clinical characteristics and risk factors of infectious mononucleosis in children with splenomegaly.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The initial Epstein-Barr virus infection in children often presents as infectious mononucleosis (IM). However, the risk factors for splenomegaly in IM remain unclear. This study investigated the clinical features and risk factors for splenomegaly in children with IM. Methods: This retrospective study enrolled children diagnosed with IM between 2019 and 2024. Participants were divided into splenomegaly and non-splenomegaly groups. The relevant clinical data and laboratory examination results of the two groups were compared. Furthermore, multivariate logistic regression and receiver operating characteristic (ROC) curve analyses were performed on the relevant variables. Results: Splenomegaly, a common clinical manifestation, was observed in 43.6% of the 179 children with IM. The splenomegaly group exhibited higher serum levels of alanine aminotransferase, r-glutamyl transpeptidase, and lactate dehydrogenase, along with higher rates of hepatomegaly and eyelid edema ( Conclusions: Older age, hepatomegaly, and eyelid edema are risk factors for splenomegaly in children with IM, with the risk increasing beyond the cut-off age of 3.5 years. These findings provide clinicians with a practical tool to identify children at higher risk and to offer advice on limiting activities to avoid potential complications, especially in settings where advanced imaging is not readily available.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.